Parker Geoffrey M.
CHIEF FINANCIAL OFFICER at ALLO; Director at ChemoCentryx, Inc.
- Sold, on record
- $3.3M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Feb 2, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ALLOAllogene Therapeutics, Inc.CHIEF FINANCIAL OFFICER
- ChemoCentryx, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ChemoCentryx, Inc.88,238 shares
- ALLO65,106 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ChemoCentryx, Inc.UnusualMay 27 2015
Sold 13,513 shares at $7.51 ($101k)
Parker Geoffrey M., Director
Sold 50% of holdings ($203k position)13,514 shares leftFirst sale on recordFiling
- 2 Form 4 sale ChemoCentryx, Inc.Plan not statedMay 30 +1464 days
Sold 12,815 shares at $12.00 ($154k)
Parker Geoffrey M., Director
Sold 15.1% of holdings ($1M position)72,199 shares leftFirst sale on recordFiling
- 3 Form 4 sale ChemoCentryx, Inc.UnusualMar 23 +298 days
Sold 30,000 shares at $36.70 ($1.1M)
Parker Geoffrey M., Director
Sold 37.7% of holdings ($2.9M position)49,600 shares leftFiling
- 4 Form 4 sale ChemoCentryx, Inc.UnusualMar 5 +347 days
Sold 31,910 shares at $56.61 ($1.8M)
Parker Geoffrey M., Director
Sold 71.5% of holdings ($2.5M position)12,690 shares leftFiling
- 5 Form 4 sale ALLONo planFeb 3 +1431 days
Sold 4,361 shares at $1.73 ($8k)
Parker Geoffrey M., CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 0.3% of holdings ($2.3M position)1.3M shares leftFirst sale on recordFiling
- 6 Form 4 sale ALLONo planOct 21 +260 days
Sold 36,744 shares at $1.26 ($46k)
Parker Geoffrey M., CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 2.8% of holdings ($1.7M position)1.3M shares leftFiling
- 7 Form 4 sale ALLONo planFeb 2 +104 days
Sold 24,001 shares at $1.76 ($42k)
Parker Geoffrey M., CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 1.9% of holdings ($2.2M position)1.3M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | ALLO | CHIEF FINANCIAL OFFICER | Form 4 sale | 24,001 | $42k | 1.9% | No plan | SEC |
| Oct 21, 2025 | ALLO | CHIEF FINANCIAL OFFICER | Form 4 sale | 36,744 | $46k | 2.8% | No plan | SEC |
| Feb 3, 2025 | ALLO | CHIEF FINANCIAL OFFICER | Form 4 sale | 4,361 | $8k | 0.3% | No plan | SEC |
| Mar 5, 2021 | ChemoCentryx, Inc. | Director | Form 4 sale | 31,910 | $1.8M | 71.5% | Unusual | SEC |
| Mar 23, 2020 | ChemoCentryx, Inc. | Director | Form 4 sale | 30,000 | $1.1M | 37.7% | Unusual | SEC |
| May 30, 2019 | ChemoCentryx, Inc. | Director | Form 4 sale | 12,815 | $154k | 15.1% | Plan not stated | SEC |
| May 27, 2015 | ChemoCentryx, Inc. | Director | Form 4 sale | 13,513 | $101k | 50.0% | Unusual | SEC |